tirzepatide injection jefferson GLP-1 weight loss drug study finds small increase in risk of osteoporosis and gout It may also help in weight management for people with obesity or overweight Our first Jefferson IPhO newsletter

Managing side effects and planning for long-term success are key to maintaining results

The FDA has consistently warned about the risks of compounded semaglutide products

And chronic back pain can be influenced by several factors, including disc degeneration, facet dysfunction, muscular instability, nerve irritation, psychosocial pain amplification, etc

One study from February 2025, for instance, suggests that people who take glucagon-like peptide-1 receptor agonist medication like Ozempic to treat diabetes have a lower depression risk than peers taking other types of drugs for this metabolic condition

The 503A pathway is not directly affected by this proposal but faces separate restrictions